Related Experiment Video
Updated: Jul 5, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
In vitro antitumor and immunomodulatory activities of 1,2,4-oxadiazole derivatives
Héverton Mendes Araújo1, Gabriel Acácio de Moura1,2, Yasmim Mendes Rocha1,2
1Post-Graduate Program in Pharmaceutical Sciences (PPGCF), Federal University of Ceará (UFC), Fortaleza, CE, Brazil.
Abstract:
Melanoma is the most aggressive and lethal type of skin cancer, responsible for approximately 60,000 deaths annually. The main strategy for treating melanoma is surgery to completely remove the lesion and its margins. However, for more advanced cases with a high recurrence rate, the preferred approach is to combine chemotherapy with immunotherapy treatments. Tumor-associated macrophages (TAMs) are the most abundant leukocytes in solid tumors. Current immunotherapy approaches target TAMs by inhibiting pro-tumoral TAMs and activating anti-tumoral TAMs, repolarizing them to the M1 phenotype. The antitumor and immunomodulatory activities of molecules derived from 1,2,4-oxadiazole, as demonstrated in the literature, highlight the potential of this class as a source of promising candidates for therapeutic applications. Thus, the present study aims to evaluate the antitumor and immunomodulatory effects of the synthetic derivative 1,2,4-oxadiazole, N-cyclohexyl-3-(3-methylphenyl)-1,2,4-oxadiazole-5-amine (1,2,4-oxadiazole derivative 2), in melanoma cells and murine Bone Marrow-Derived Macrophages (BMDMs). Cytotoxicity in B16-F10 and BMDMs cells was assessed using the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) MTT method. 1,2,4-oxadiazole derivative 2 exhibited antiproliferative effects on both cell lines, being 2.6 times more selective for B16-F10. Necrosis was identified as the active induced death pathway. BMDMs isolated and exposed to 1,2,4-oxadiazole derivative 2 polarize to the M1 phenotype and induce TNF-α at a concentration of 64.34 μM. Exposure to melanoma murine supernatants also promotes M1 polarization. Supernatants containing traces of 1,2,4-oxadiazole derivative 2 (Supernatants B, C, and D) increased the percentage of M1 cells compared to Supernatant A, as well as elevated levels of nitrite, TNF-α, and IL-12. 1,2,4-oxadiazole derivative 2 combined with Supernatant A and 1,2,4-oxadiazole derivative 2 combined with LPS also resulted in higher M1 polarization, suggesting a synergistic effect on M1 polarization and TNF-α production. Our findings underscore the significance of the 1,2,4-oxadiazole compound class and highlight the potential of 1,2,4-oxadiazole derivative 2 as an antitumoral and immunotherapeutic agent.
Insights
This study shows that 1,2,4-oxadiazole derivative 2 has antitumor effects against melanoma cells and can repolarize tumor-associated macrophages (TAMs) to an M1 phenotype, enhancing immune response.
Area of Science:
- Immunology
- Oncology
- Medicinal Chemistry
Background:
- Melanoma, a lethal skin cancer, often requires combination therapy for advanced cases.
- Tumor-associated macrophages (TAMs) are key players in tumor immunity, with M1 polarization showing anti-tumor effects.
- 1,2,4-oxadiazole derivatives show promise as therapeutic agents due to their antitumor and immunomodulatory activities.
Purpose of the Study:
- To evaluate the antitumor and immunomodulatory effects of the synthetic 1,2,4-oxadiazole derivative 2.
- To assess the compound's impact on melanoma cells and murine Bone Marrow-Derived Macrophages (BMDMs).
Main Methods:
- Cytotoxicity was assessed using the MTT assay on B16-F10 melanoma cells and BMDMs.
- Macrophage polarization to M1 phenotype and cytokine production (TNF-α, nitrite, IL-12) were analyzed.
- Synergistic effects were investigated by combining the derivative with melanoma supernatants and LPS.
Main Results:
- 1,2,4-oxadiazole derivative 2 demonstrated antiproliferative effects on B16-F10 cells and BMDMs, with higher selectivity for melanoma cells.
- The compound induced necrosis in cancer cells and promoted M1 polarization in BMDMs, increasing TNF-α production.
- Combinations of the derivative with melanoma supernatants or LPS showed synergistic effects on M1 polarization and TNF-α production.
Conclusions:
- 1,2,4-oxadiazole derivative 2 exhibits significant antitumor and immunomodulatory potential.
- The compound effectively repolarizes macrophages to an anti-tumor M1 phenotype.
- This derivative represents a promising candidate for novel antitumoral and immunotherapeutic strategies against melanoma.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy

